Undeterred, Pfizer continues its mega merger strategy

Pfizer continues to stalk AstraZeneca, even as other firms abandon mega mergers.

This entry was posted in Pharmaceutical Industry and tagged , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.